1170317

UCB Pharma S.A. — FEI 3003909356

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 25, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Braine-L'Alleud (Belgium)

Additional Details

Mutual Recognition Agreement (MRA)